Kernodle & Katon Asset Management Group’s St Jude Medical STJ Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-225	Closed	-$18K	–	345
2016 Q3	$18K	Hold	225	–	–	0.01%	223
2016 Q2	$18K	Hold	225	–	–	0.02%	188
2016 Q1	$12K	Hold	225	–	–	0.01%	206
2015 Q4	$14K	Buy	+225	New	+$14.2K	0.01%	189

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kernodle & Katon Asset Management Group's STJ Position: Q4 2016 in Review

Kernodle & Katon Asset Management Group sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 225 shares — an estimated $18K sold.

Kernodle & Katon Asset Management Group first reported a position in STJ in Q4 2015 and held it in 4 quarters. The position peaked at $18K in Q3 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

Kernodle & Katon Asset Management Group reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
Kernodle & Katon Asset Management Group sold 225 St Jude Medical shares in Q4 2016, an estimated $18K.
Kernodle & Katon Asset Management Group first reported a position in St Jude Medical in Q4 2015 and held it in 4 quarters.
Kernodle & Katon Asset Management Group's St Jude Medical position peaked at $18K in Q3 2016.
551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q4 2016, filed 14 Feb 2017.